Soligenix, Inc. Gains 78.42%
Mon, Aug 18, 2025 at 07:43 PM
Soligenix, Inc. (SNGX:NASDAQ) soared at $4.96, a gain of 78.4%. On Mon, Aug 18, 2025, SNGX:NASDAQ touched a New 2-Week High of $4.96. The stock appeared on our News Catalysts scanner on Mon, Aug 18, 2025 at 09:31 AM in the 'BIOTECH' category. From Mon, Aug 04, 2025, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Aug 18, 2025 at $6.23 with a volume of 181M+.
About Soligenix, Inc. (SNGX:NASDAQ)
Soligenix Inc is a clinical stage biopharmaceutical company focused on focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 350%
- Soligenix, Inc. (SNGX:NASDAQ), 78.42%
- Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ), 64.35%
- Catheter Precision, Inc. (VTAK:NYSEMKT), 62.84%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 50.69%
- Xunlei Limited (XNET:NASDAQ), 37.56%
- GoodRx Holdings, Inc. (GDRX:NASDAQ), 37.27%
- Burning Rock Biotech Limited (BNR:NASDAQ), 35.96%
- ImmunoPrecise Antibodies Ltd. (IPA:NASDAQ), 35%
- Iron Horse Acquisitions Corp. (IROH:NASDAQ), 29.86%